Leerink Partners Maintains Market Perform on Amgen, Raises Price Target to $464
Benzinga Newsdesk 19 hours ago
Analyst RatingsNewsPrice TargetHot
Leerink Partners analyst David Risinger maintains Amgen (NASDAQ:AMGN) with a Market Perform and raises the price target from $395 to $464.
Leerink Partners analyst David Risinger maintains Amgen (NASDAQ:AMGN) with a Market Perform and raises the price target from $395 to $464.